Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 12;10(3):193.
doi: 10.3390/gels10030193.

Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery

Affiliations

Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery

Fabrizio Villapiano et al. Gels. .

Abstract

This study endeavored to overcome the physiological barriers hindering optimal bioavailability in ophthalmic therapeutics by devising drug delivery platforms that allow therapeutically effective drug concentrations in ocular tissues for prolonged times. Thermosensitive drug delivery platforms were formulated by blending poloxamers (F68 and F127) with low-molecular-weight hyaluronic acid (HA) in various concentrations and loaded with hydrocortisone (HC). Among the formulations examined, only three were deemed suitable based on their desirable gelling properties at a temperature close to the eye's surface conditions while also ensuring minimal gelation time for swift ocular application. Rheological analyses unveiled the ability of the formulations to develop gels at suitable temperatures, elucidating the gel-like characteristics around the physiological temperature essential for sustained drug release. The differential scanning calorimetry findings elucidated intricate hydrogel-water interactions, indicating that HA affects the water-polymer interactions within the gel by increasing the platform hydrophilicity. Also, in vitro drug release studies demonstrated significant hydrocortisone release within 8 h, governed by an anomalous transport mechanism, prompting further investigation for optimized release kinetics. The produced platforms offer promising prospects for efficacious ocular drug delivery, addressing pivotal challenges in ocular therapeutics and heralding future advancements in the domain.

Keywords: DSC; hyaluronic acid; hydrocortisone release kinetics; hydrogels; in situ forming drug reservoir; ophthalmic drug delivery; thermosensitive systems.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Fourier transform infrared spectra (FTIR) of raw materials and selected hydrogels (left). Scanning electron microscopy (SEM) micrographs of freeze-dried hydrogels with (right) or without HC (left).
Figure 2
Figure 2
Mechanical spectra of unloaded pol/HA platforms at three different temperatures: 4 °C (A), 25 °C (B) and 37 °C (C).
Figure 3
Figure 3
Elastic and viscous moduli as a function of temperature, at a fixed frequency of 1 Hz for formulations P3/0.1, P3/1 and P4/0.1, unloaded (left) and HC loaded (right). The error bars are omitted for clarity purpose.
Figure 4
Figure 4
Thermograms of (A) P3/0.1; (B) P3/1; (C) P4/0.1.
Figure 5
Figure 5
Swelling ratio of dried gel formulations.
Figure 6
Figure 6
Hydrocortisone release curves from pol/HA gels.

References

    1. Gaudana R., Ananthula H.K., Parenky A., Mitra A.K. Ocular Drug Delivery. AAPS J. 2010;12:348–360. doi: 10.1208/s12248-010-9183-3. - DOI - PMC - PubMed
    1. Jumelle C., Gholizadeh S., Annabi N., Dana R. Advances and Limitations of Drug Delivery Systems Formulated as Eye Drops. J. Control. Release. 2020;321:1–22. doi: 10.1016/j.jconrel.2020.01.057. - DOI - PMC - PubMed
    1. Grassiri B., Zambito Y., Bernkop-Schnürch A. Strategies to Prolong the Residence Time of Drug Delivery Systems on Ocular Surface. Adv. Colloid. Interface Sci. 2021;288:102342. doi: 10.1016/j.cis.2020.102342. - DOI - PubMed
    1. Mofidfar M., Abdi B., Ahadian S., Mostafavi E., Desai T.A., Abbasi F., Sun Y., Manche E.E., Ta C.N., Flowers C.W. Drug Delivery to the Anterior Segment of the Eye: A Review of Current and Future Treatment Strategies. Int. J. Pharm. 2021;607:120924. doi: 10.1016/j.ijpharm.2021.120924. - DOI - PMC - PubMed
    1. Arrigo A., Aragona E., Bandello F. VEGF-Targeting Drugs for the Treatment of Retinal Neovascularization in Diabetic Retinopathy. Ann. Med. 2022;54:1089–1111. doi: 10.1080/07853890.2022.2064541. - DOI - PMC - PubMed

LinkOut - more resources